Regenxbio Inc (RGNX)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	-268,128	-261,996	-268,081	-257,506	-262,876	108,491	122,188	132,495	159,980	-207,267	-135,968	-125,575	-119,233	-105,906	-155,753	-150,792	-148,998	-106,224	-93,053	-49,831
Total assets	US$ in thousands	573,970	633,786	682,458	747,830	833,268	883,793	953,444	1,025,370	1,113,900	800,395	836,402	879,442	708,164	541,174	449,738	463,936	497,908	509,237	529,139	519,031
Operating ROA		-46.71%	-41.34%	-39.28%	-34.43%	-31.55%	12.28%	12.82%	12.92%	14.36%	-25.90%	-16.26%	-14.28%	-16.84%	-19.57%	-34.63%	-32.50%	-29.92%	-20.86%	-17.59%	-9.60%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $-268,128K ÷ $573,970K
= -46.71%

The operating return on assets (ROA) for Regenxbio Inc has experienced a downward trend over the past eight quarters, highlighting a decline in the company's ability to generate operating profit from its assets. In Q4 2023, the operating ROA reached -46.71%, indicating that the company generated a negative return on its assets during this period. This was a significant decrease from the previous quarter's operating ROA of -41.34% and continued the trend of worsening performance from Q2 2023 (-39.28%) and Q1 2023 (-34.43%).

Comparing the latest data to the same quarter in the previous year, there has been a substantial deterioration in performance, as seen from the sharp drop from a positive operating ROA of 12.82% in Q4 2022 to the current negative return. This suggests potential operational challenges or inefficiencies that have impacted the company's ability to effectively utilize its assets to generate profits.

Overall, the negative operating ROA figures indicate that Regenxbio Inc is struggling to effectively leverage its assets to generate operating income, which may be a cause for concern among investors and stakeholders. Further analysis and investigation into the company's operational strategies and financial performance are warranted to address these declining trends and work towards improving the company's profitability and efficiency.